It has been proposed that sinomenine hydrochloride may have therapeutic effects on plasma cell mastitis based on its anti–inflammatory and immunomodulatory properties, which are exerted through the downregulation of the IL–6/JAK2/STAT–3 pathway [58]. The gene discussed is IL6; the disease is mastitis.